|
Sign In to gain access to subscriptions and/or personal tools.
|
Wegener's granulomatosis: disease course, assessment of activity and extent and treatment
K de Groot
W L Gross
Medizinische Universität Luëbeck, Abteilung Klinische Rheumatologie, Oskar-Alexander-Straße 26, D-24572 Bad Bramstedt, Germany
Wegener's granulomatosis (WG) belongs to the group of necrotizing primary systemic vasculitides of unknown etiology, that are associated with anti-neutrophil cytoplasmic antibodies. The pathological hallmark of WG is the coexistence of vasculitis and granuloma. Due to more sensitive diagnostic instruments, especially ANCA testing, the incidence of diagnosis of WG has risen in the past ten years. Although the precise pathophysiology is not understood yet, there is ample evidence that ANCA, which can lead to cytotoxic reactions in the vascular texture, play a major role, possibly promoted by a dysbalance in the anti-idiotypic network. The clinical disease course is typically two-phasic, beginning with a granulomatous inflammation of the upper respiratory tract, that usually is followed by a generalized vasculitic phase, that can range from mild organ dysfuntion to lifethreatening multi-organ failure. Consequently, diagnostic procedures, patients' assessment and therapeutic regimens need to be individualized, adapted to stage and activity of the disease as well as standardized.
Key Words: Wegener's granulomatosis • PR3-ANCA • disease activity and extent • stage adapted therapy
Lupus, Vol. 7, No. 4,
285-291 (1998)
DOI: 10.1191/096120398678920118
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J. C. Finley Jr, D. C. Bloom, and J. K. Thiringer
Wegener Granulomatosis Presenting as an Infiltrative Retropharyngeal Mass With Syncope and Hypoglossal Paresis
Arch Otolaryngol Head Neck Surg,
March 1, 2004;
130(3):
361 - 365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Koldingsnes and H. Nossent
Predictors of survival and organ damage in Wegener's granulomatosis
Rheumatology,
May 1, 2002;
41(5):
572 - 581.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hattar, U. Grandel, A. Bickenbach, A. Schwarting, W.-J. Mayet, J. Bux, S. Jessen, C. Fischer, W. Seeger, F. Grimminger, et al.
Interaction of Antibodies to Proteinase 3 (Classic Anti-Neutrophil Cytoplasmic Antibody) with Human Renal Tubular Epithelial Cells: Impact on Signaling Events and Inflammatory Mediator Generation
J. Immunol.,
March 15, 2002;
168(6):
3057 - 3064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P Lamprecht, F Moosig, A Gause, K Herlyn, E Csernok, H Hansen, and W L Gross
Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis
Ann Rheum Dis,
April 1, 2001;
60(4):
385 - 390.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Schonermarck, P. Lamprecht, E. Csernok, and W. L. Gross
Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA
Rheumatology,
February 1, 2001;
40(2):
178 - 184.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. L. Gross, A. Trabandt, and E. Reinhold-Keller
Diagnosis and evaluation of vasculitis
Rheumatology,
March 1, 2000;
39(3):
245 - 252.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Knight, M. J. Hayduk, D.-J. Summerlin, and G. W. Mirowski
"Strawberry" Gingival Hyperplasia: A Pathognomonic Mucocutaneous Finding in Wegener Granulomatosis
Arch Dermatol,
February 1, 2000;
136(2):
171 - 173.
[Full Text]
[PDF]
|
|
|
|
|
